News | October 13, 2021
PCI Pharma Services acquires LSNE for its CDMO business
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
The injection is used to reverse the effects of the muscle relaxants given to patients during surgery
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
Labetalol hydrochloride injection USP is indicated for the control of blood pressure in severe hypertension.
This is Omeza’s first Rx product and the first drug/device combination matrix of its kind for chronic wound care
The product will be available in 500 mg/2.5 mL and 1 g/5 mL vials
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT
The drug is indicated for mild and transient episodes of heart block
Subscribe To Our Newsletter & Stay Updated
